Related Experiment Video
Updated: Mar 25, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Small molecules reveal an alternative mechanism of Bax activation
Hetal Brahmbhatt1, David Uehling2, Rima Al-Awar2
1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada, L8S 4L8 Department of Biological Sciences, Sunnybrook Research Institute, University of Toronto, ON, Canada, M4N 3M5.
Abstract:
The pro-apoptotic protein Bax commits a cell to death by permeabilizing the mitochondrial outer membrane (MOM). To obtain small-molecule probes for elucidating the molecular mechanism(s) of Bax activation, we screened for compounds that induced Bax-mediated liposome permeabilization. We identified five structurally different small molecules that promoted both Bax targeting to and oligomerization at membranes. All five compounds initiated Bax oligomerization in the absence of membranes by a mechanism unlike Bax activation by Bcl-2 homology 3 domain (BH3) proteins. Some of the compounds induced Bax/Bak-dependent apoptosis in cells. Activation of Bax by the most active compound was poorly inhibited by the anti-apoptotic protein Bcl-XL and requires a cysteine residue at position 126 of Bax that is not required for activation by BH3 proteins. Our results reveal a novel pathway for Bax activation independent of pro-apoptotic BH3 proteins that may have important implications for the regulation of Bax activity in cells.
Insights
Researchers discovered new small molecules that activate the pro-apoptotic protein Bax, independent of known pathways. These compounds trigger Bax oligomerization and cell death, offering novel insights into apoptosis regulation.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- The pro-apoptotic protein Bax initiates programmed cell death by permeabilizing the mitochondrial outer membrane (MOM).
- Understanding Bax activation mechanisms is crucial for controlling cell death pathways.
Purpose of the Study:
- To identify small-molecule probes that elucidate Bax activation mechanisms.
- To discover novel pathways for Bax activation.
Main Methods:
- Screening for compounds inducing Bax-mediated liposome permeabilization.
- Assessing compound effects on Bax targeting, oligomerization, and membrane interaction.
- Evaluating compound-induced apoptosis in cells.
- Investigating the role of specific Bax residues and inhibition by Bcl-XL.
Main Results:
- Five structurally distinct small molecules were identified that promote Bax targeting and oligomerization at membranes.
- These compounds initiated Bax oligomerization independently of membranes and BH3 proteins.
- Some compounds induced Bax/Bak-dependent apoptosis in cells.
- The most active compound's Bax activation was poorly inhibited by Bcl-XL and required Cys126, unlike BH3-mediated activation.
Conclusions:
- A novel pathway for Bax activation, independent of pro-apoptotic BH3 proteins, has been revealed.
- These findings suggest new strategies for regulating Bax activity and cell death.
- The identified small molecules serve as valuable probes for studying Bax function.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Caspases
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Amplifying Signals via Enzymatic Cascade

